Cite
HARVARD Citation
Ong, E. et al. (n.d.). Dramatic improvement after rituximab in a patient with paraneoplastic treatment‐refractory Morvan syndrome associated with anti‐CASPR2 antibodies. European journal of neurology. 20 (7), pp. e96-e97. [Online].